Literature DB >> 7929803

Alterations in interleukin-4 and antibody production following pheromone exposure: role of glucocorticoids.

J A Moynihan1, J D Karp, N Cohen, R Cocke.   

Abstract

We have previously shown that exposure to pheromones from footshock-stressed mice suppresses cell-mediated immunity and enhances humoral immunity. Here we show that stress odor exposure is associated with enhanced antigen-specific antibody production and interleukin (IL)-4 production in BALB/c, but not C57Bl/6, mice. Glucocorticoid receptor antagonism blocks the enhancement of IL-4, but not antibody titers. There is an apparent differential sensitivity of BALB/c and C57Bl/6 spleen cells to in vitro incubation with the synthetic glucocorticoid dexamethasone; IL-2 production by BALB/c spleen cells is more sensitive to the effects of steroid. These data suggest that C57Bl/6 mice may not respond to stress pheromones due to their relative insensitivity to endogenous steroids.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7929803     DOI: 10.1016/0165-5728(94)90230-5

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  3 in total

1.  Apomorphine-susceptible and apomorphine-unsusceptible Wistar rats differ in their susceptibility to inflammatory and infectious diseases: a study on rats with group-specific differences in structure and reactivity of hypothalamic-pituitary-adrenal axis.

Authors:  A Kavelaars; C J Heijnen; B Ellenbroek; H van Loveren; A Cools
Journal:  J Neurosci       Date:  1997-04-01       Impact factor: 6.167

Review 2.  Glucocorticoids-All-Rounders Tackling the Versatile Players of the Immune System.

Authors:  Cindy Strehl; Lisa Ehlers; Timo Gaber; Frank Buttgereit
Journal:  Front Immunol       Date:  2019-07-24       Impact factor: 7.561

Review 3.  Neuroendocrine Regulation of Tumor-Associated Immune Cells.

Authors:  Claudia B Colon-Echevarria; Rocio Lamboy-Caraballo; Alexandra N Aquino-Acevedo; Guillermo N Armaiz-Pena
Journal:  Front Oncol       Date:  2019-10-29       Impact factor: 6.244

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.